Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Crispim 2019 MitoFit Preprint Arch EA"

From Bioblast
(10 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{MitoFit page name}}
{{MitoFit page name}}
{{Publication
{{Publication
|title=Crispim Marcell , Verdaguer IB, Katzin AM (2019) Effects of atovaquone and 4-nitrobenzoate on ''Plasmodium falciparum'' respiration. MitoFit Preprint Arch  doi:10.26124/mitofit:ea19.MiPSchool.0007.
|title=Crispim M, Verdaguer IB, Zafra CA, Katzin AM (2019) Effects of atovaquone and 4-nitrobenzoate on ''Plasmodium falciparum'' respiration. MitoFit Preprint Arch  [[doi:10.26124/mitofit:ea19.MiPSchool.0007.v2]].
|info=[[File:MitoFit Preprint Arch pdf.png|left|160px|link=https://wiki.oroboros.at/images/8/81/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.pdf |MitoFit pdf]]  <big><big>'''[https://wiki.oroboros.at/images/8/81/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.pdf Effects of atovaquone and 4-nitrobenzoate on ''Plasmodium falciparum'' respiration]'''</big></big>
|info=[[File:MitoFit Preprint Arch pdf.png|left|160px|link=https://www.mitofit.org/images/6/68/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.v2.pdf |MitoFit pdf]]  <big><big>'''[https://www.mitofit.org/images/6/68/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.v2.pdf Effects of atovaquone and 4-nitrobenzoate on ''Plasmodium falciparum'' respiration]'''</big></big>
|authors=Crispim M, Verdaguer IB, Katzin AM
|authors=Crispim M, Verdaguer IB, Zafra CA, Katzin AM
|year=2019
|year=2019-06-27
|journal=MitoFit Preprint Arch
|journal=MitoFit Preprint Arch
|abstract=Version 1 ('''v1''') '''2019-06-17''' [https://wiki.oroboros.at/images/8/81/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.pdf doi:10.26124/mitofit:ea19.MiPSchool.0007]
|abstract=>>Versions: ('''v2''') '''2019-06-27''' [https://www.mitofit.org/images/6/68/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.v2.pdf doi:10.26124/mitofit:ea19.MiPSchool.0007.v2]; v1 2019-06-17 [https://wiki.oroboros.at/images/8/81/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.pdf doi:10.26124/mitofit:ea19.MiPSchool.0007]
::: <small>Versions [https://wiki.oroboros.at/images/8/81/Crispim_2019_MitoFit_Preprint_Arch_doi_10.26124mitofitea19.MiPSchool.0007.pdf doi:10.26124/mitofit:ea19.MiPSchool.0007]


Although atovaquone is one of the newest antimalarial compounds discovered, resistant parasites have already been reported1. Atovaquone mechanism of action is established to be the competition with ubiquinol (UQH2) for the bc1 union at mitochondrial cytochrome bc1 complex and preventing the parasite from maintaining an oxidized ubiquinone (UQ) pool, essential for the DHODH activity and consequently for the pyrimidine's biosynthesis. In this sense, possible inhibitors of the ubiquinone biosynthesis pathway would be candidates by stimulating the effects of atovaquone. 4-nitrobenzoate (4-NB) is a well-known inhibitor of 4HPT (4-hydroxybenzoate polyprenyltransferase), the first enzyme of UQ biosynthesis. 4-NB also showed an important effect on reducing the UQs pool in P. falciparum. Herein is presenting the effect of atovaquone and 4-NB on parasitic respiration UQ biosynthesis. The purpose of this study was to better understand the atovaquone mechanism of action in a molecular scale, drug target potential of UQ biosynthesis. Oxygen consumption assays revealed 4-NB potentiates atovaquone mitochondrial effects and showed itself the ability to decrease the respiration rate. - ''Extended abstract''
 
== Although atovaquone is one of the newest antimalarial compounds discovered, resistant parasites have already been reported1. Atovaquone mechanism of action is established to be the competition with ubiquinol (UQH2) for the bc1 union at mitochondrial cytochrome bc1 complex and preventing the parasite from maintaining an oxidized ubiquinone (UQ) pool, essential for the DHODH activity and consequently for the pyrimidine's biosynthesis. In this sense, possible inhibitors of the ubiquinone biosynthesis pathway would be candidates by stimulating the effects of atovaquone. 4-nitrobenzoate (4-NB) is a well-known inhibitor of 4HPT (4-hydroxybenzoate polyprenyltransferase), the first enzyme of UQ biosynthesis. 4-NB also showed an important effect on reducing the UQs pool in P. falciparum. Herein is presenting the effect of atovaquone and 4-NB on parasitic respiration UQ biosynthesis. The purpose of this study was to better understand the atovaquone mechanism of action in a molecular scale, drug target potential of UQ biosynthesis. Oxygen consumption assays revealed 4-NB potentiates atovaquone mitochondrial effects and showed itself the ability to decrease the respiration rate. ==
- ''Extended abstract''
|keywords=
|keywords=
|editor=[[Iglesias-Gonzalez J]]
|editor=[[Iglesias-Gonzalez J]]
Line 15: Line 18:


== Affiliations ==
== Affiliations ==
Crispim Marcell(1) , Verdaguer IB(1), Katzin AM(1)
Crispim Marcell(1) , Verdaguer IB(1), Zafra CA(1), Katzin AM(1)
::::# Dept. of Parasitology, Laboratório de Malária, Univ. of Sao Paulo, Sao Paulo, Brazil. Av. Prof. Lineu Prestes, 1374 - Edifício Biomédicas II - Cidade Universitária "Armando Salles Oliveira" - CEP: 05508-000.- [email protected]
::::# Dept. of Parasitology, Laboratório de Malária, Univ. of Sao Paulo, Sao Paulo, Brazil. Av. Prof. Lineu Prestes, 1374 - Edifício Biomédicas II - Cidade Universitária "Armando Salles Oliveira" - CEP: 05508-000.- [email protected]


Line 24: Line 27:
== References ==
== References ==
:::# Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S (2018) Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother 73(3):581-595.
:::# Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S (2018) Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother 73(3):581-595.
:::# Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. J
:::# Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. J Parasitol 91(3):484-6.
Parasitol 91(3):484-6.
:::# Tonhosolo R, Gabriel HB, Matsumura HY, Cabral FJ, Yamamoto MM, D’Alexandri FL, Sussmann RAC, Belmonte R, Peres VJ, Crick DC, Wunderlich G, Kimura EA, Katzin AM (2010) Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone. FEBS Lett 584: 4761–4768.
:::# Tonhosolo R, Gabriel HB, Matsumura HY, Cabral FJ, Yamamoto MM, D’Alexandri FL, Sussmann RAC, Belmonte R, Peres VJ, Crick DC, Wunderlich G, Kimura EA, Katzin AM (2010) Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone. FEBS Lett 584: 4761–4768.
:::# Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol 65:  418–20.
:::# Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol 65:  418–20.
Line 31: Line 33:
:::# Forsman U, Sjöberg M, Turunen M, Sindelar PJ (2010) 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. Nat Chem Biol 6(7):515-7.  
:::# Forsman U, Sjöberg M, Turunen M, Sindelar PJ (2010) 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. Nat Chem Biol 6(7):515-7.  


== Event ==
::::» [[MiPschool Coimbra 2019]]
== Preprints for [[Gentle Science]] ==
{{MitoFit preprint}}


{{Labeling
{{Labeling
Line 40: Line 48:
|couplingstates=
|couplingstates=
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=Preprints
}}
}}

Revision as of 16:35, 30 November 2020


MitoFit Preprints         MitoFit Preprints        
Gnaiger 2019 MitoFit Preprints
       
Gnaiger MitoFit Preprints 2020.4
        MitoFit DOI Data Center         MitoPedia: Preprints         Bioenergetics Communications


Crispim 2019 MitoFit Preprint Arch EA

Publications in the MiPMap
Crispim M, Verdaguer IB, Zafra CA, Katzin AM (2019) Effects of atovaquone and 4-nitrobenzoate on Plasmodium falciparum respiration. MitoFit Preprint Arch doi:10.26124/mitofit:ea19.MiPSchool.0007.v2.

»

MitoFit pdf

Effects of atovaquone and 4-nitrobenzoate on Plasmodium falciparum respiration

Crispim M, Verdaguer IB, Zafra CA, Katzin AM (2019-06-27) MitoFit Preprint Arch

Abstract: >>Versions: (v2) 2019-06-27 doi:10.26124/mitofit:ea19.MiPSchool.0007.v2; v1 2019-06-17 doi:10.26124/mitofit:ea19.MiPSchool.0007

Versions doi:10.26124/mitofit:ea19.MiPSchool.0007


Although atovaquone is one of the newest antimalarial compounds discovered, resistant parasites have already been reported1. Atovaquone mechanism of action is established to be the competition with ubiquinol (UQH2) for the bc1 union at mitochondrial cytochrome bc1 complex and preventing the parasite from maintaining an oxidized ubiquinone (UQ) pool, essential for the DHODH activity and consequently for the pyrimidine's biosynthesis. In this sense, possible inhibitors of the ubiquinone biosynthesis pathway would be candidates by stimulating the effects of atovaquone. 4-nitrobenzoate (4-NB) is a well-known inhibitor of 4HPT (4-hydroxybenzoate polyprenyltransferase), the first enzyme of UQ biosynthesis. 4-NB also showed an important effect on reducing the UQs pool in P. falciparum. Herein is presenting the effect of atovaquone and 4-NB on parasitic respiration UQ biosynthesis. The purpose of this study was to better understand the atovaquone mechanism of action in a molecular scale, drug target potential of UQ biosynthesis. Oxygen consumption assays revealed 4-NB potentiates atovaquone mitochondrial effects and showed itself the ability to decrease the respiration rate.

- Extended abstract

Bioblast editor: Iglesias-Gonzalez J


Affiliations

Crispim Marcell(1) , Verdaguer IB(1), Zafra CA(1), Katzin AM(1)

  1. Dept. of Parasitology, Laboratório de Malária, Univ. of Sao Paulo, Sao Paulo, Brazil. Av. Prof. Lineu Prestes, 1374 - Edifício Biomédicas II - Cidade Universitária "Armando Salles Oliveira" - CEP: 05508-000.- [email protected]


Results

Crispim 2019 MitoFit Preprin Arch EA Figure 1.png

References

  1. Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S (2018) Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. J Antimicrob Chemother 73(3):581-595.
  2. Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. J Parasitol 91(3):484-6.
  3. Tonhosolo R, Gabriel HB, Matsumura HY, Cabral FJ, Yamamoto MM, D’Alexandri FL, Sussmann RAC, Belmonte R, Peres VJ, Crick DC, Wunderlich G, Kimura EA, Katzin AM (2010) Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone. FEBS Lett 584: 4761–4768.
  4. Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol 65: 418–20.
  5. Murphy AD, Doeller JE, Hearn B, Lang-Unnasch N (1997) Plasmodium falciparum: cyanide-resistant oxygen consumption, Exp Parasitol 87: 112–120.
  6. Forsman U, Sjöberg M, Turunen M, Sindelar PJ (2010) 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. Nat Chem Biol 6(7):515-7.

Event

» MiPschool Coimbra 2019


Preprints for Gentle Science

MitoFit Preprints.png

» MitoFit Preprints - the Open Access preprint server for mitochondrial physiology and bioenergetics

» MitoPedia: Preprints


Labels:





HRR: Oxygraph-2k 

Preprints